DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,009,521 | -30.1% | 335,884 | -12.2% | 0.04% | -31.4% |
| Q2 2023 | $4,303,980 | -6.1% | 382,576 | -42.6% | 0.05% | -28.2% |
| Q2 2022 | $4,582,000 | -41.5% | 666,997 | -18.0% | 0.07% | -44.1% |
| Q1 2022 | $7,839,000 | +28.1% | 813,139 | +58.0% | 0.13% | +44.3% |
| Q4 2021 | $6,119,000 | +74.3% | 514,601 | +138.0% | 0.09% | +54.4% |
| Q3 2021 | $3,511,000 | -25.0% | 216,201 | -2.8% | 0.06% | -34.5% |
| Q2 2021 | $4,679,000 | -21.2% | 222,374 | -41.9% | 0.09% | -34.1% |
| Q1 2021 | $5,940,000 | -42.4% | 382,493 | -22.1% | 0.13% | -51.6% |
| Q4 2020 | $10,311,000 | +91.4% | 490,986 | +84.0% | 0.27% | +54.2% |
| Q3 2020 | $5,387,000 | – | 266,799 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |